On now! @abhiAsolanki discussing the management of locally recurrent prostate cancer after EBRT #ASTRO20 #pcsm #radonc
Great discussion of patient selection for salvage therapies and potential outcomes.
Bottom line, we need clinical trials!
Bottom line, we need clinical trials!
Now @RobertDen6 discussing Radium-223
Are there biomarkers to follow response? ALP
https://abs.twimg.com/emoji/v2/... draggable="false" alt="👇" title="Rückhand Zeigefinger nach unten" aria-label="Emoji: Rückhand Zeigefinger nach unten">
Are there biomarkers to follow response? ALP
Novel androgen receptor antagonists that the #radonc should know about
https://abs.twimg.com/emoji/v2/... draggable="false" alt="👇" title="Rückhand Zeigefinger nach unten" aria-label="Emoji: Rückhand Zeigefinger nach unten"> #ASTRO20
And now case discussions led by @jennamkahn with @RobertDen6 @abhiAsolanki and @DrSpratticus #ASTRO20
Discussion of low volume M1 and local recurrence after brachytherapy. Challenging cases we are encountering with increasing frequency in the clinic.
#ASTRO20
#ASTRO20